Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B2receptor: application to cytofluorometry and imaging.
BACKGROUND
We have previously reported the design, pharmacological properties and imaging application of bradykinin (BK) B2receptor (B2R) ligands conjugated with fluorophores such as fluorescein derivatives at their N-terminus. To take advantage of the high penetration of infrared light into living tissues and their low autofluorescence in this region of the spectrum, additional probes conjugated with cyanine dye 7 (Cy7) were synthesized and characterized.


RESULTS
The antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-BK) and the agonist B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-BK) were N-terminally extended with the infrared fluorophore Cy7, producing the peptides B-10665 and B-10666, respectively. Pharmacological studies indicated that the agonist B-10666 lost much affinity for the B2R vs. the parent peptide, whereas the antagonist B-10665 better retained its potency vs. B-9430 (competition of [3H]BK binding to human B2R, contractility of the human isolated umbilical vein for which potency losses were more important in each case). Both probes stained HEK 293 cells that expressed the B2R-green fluorescent protein (GFP) construction in a specific manner (confocal microscopy) and with very extensive co-localization of the green and infrared fluorescence in either case. The agonist B-10666 at 100 nM promoted the endocytosis of B2R-GFP in live cells, but not the antagonist version at 10-25 nM. The Cy7-labeled peptides did not label cells expressing the β2-adrenoceptor-GFP construction. B-10665 at low nanomolar concentrations was an effective probe for the recombinant B2Rs in cytofluorometry and macroscopic imaging of cell wells (IVIS imaging system operated for infrared fluorescence detection).


CONCLUSIONS
Despite a propensity for non-specific binding when used at high concentrations and limited sensitivity, Cy7-conjugated peptidase-resistant B2R ligands support original imaging and cytofluorometric applications.
Department of Biochemistry, University of Colorado Denver, Aurora, CO, 80045, USA.
Lajos
L
Gera
Axe maladies infectieuses et immunitaires, Centre de recherche, CHU de Québec Université Laval, Quebec, QC, G1V 4G2, Canada.
Xavier
X
Charest-Morin
Axe endocrinologie et néphrologie, Centre de recherche, CHU de Québec Université Laval, Quebec, QC, G1V 4G2, Canada.
Melissa
M
Jean
Axe endocrinologie et néphrologie, Centre de recherche, CHU de Québec Université Laval, Quebec, QC, G1V 4G2, Canada.
Hélène
H
Bachelard
Centre de Recherche du CHU de Québec (CHUL), Room T1-49, 2705 Boulevard Laurier, Quebec City, QC, G1V 4G2, Canada. francois.marceau@crchul.ulaval.ca.
François
http://orcid.org/0000-0003-1691-6083
F
Marceau
Bradykinin B2 receptors; Cyanine dye 7; Cytofluorometry; Fluorescence; Human umbilical vein; Microscopy
Peptides. 2008 Sep;29(9):1626-30
18565624
Hypertension. 2000 Jun;35(6):1319-25
10856284
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3684-9
10725388
J Pharmacol Exp Ther. 2007 Nov;323(2):534-46
17699739
Int Immunopharmacol. 2010 Nov;10(11):1344-53
20831918
J Pharmacol Exp Ther. 2011 Apr;337(1):33-41
21205920
Pharmacol Res. 2013 May;71:44-52
23454239
Pharmacol Res Perspect. 2015 Mar;3(2):e00119
26038695
J Pharmacol Exp Ther. 1994 Jun;269(3):1136-43
8014858
Br J Pharmacol. 2008 Mar;153(5):947-55
18084312
Peptides. 2008 Apr;29(4):606-12
18201802
Peptides. 2012 Apr;34(2):433-46
22349904
Peptides. 2010 Aug;31(8):1546-54
20452384
Am J Physiol Heart Circ Physiol. 2001 Jul;281(1):H275-83
11406494